← Back to Search

HOP-STEP Program for Lupus (HOP-STEP sIRB Trial)

N/A
Waitlist Available
Led By Megan E Clowse, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
adult and/or pediatric clinical rheumatology providers within UCMC clinic
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intervention period, up to 12 months
Awards & highlights

HOP-STEP sIRB Trial Summary

This trial seeks to fit and pilot an intervention to improve maternal outcomes at The University of Chicago Medical Center.

Who is the study for?
This trial is for clinical rheumatology providers at the University of Chicago Medical Center. It aims to improve maternal health in women with lupus by educating providers on pregnancy planning and contraception.Check my eligibility
What is being tested?
The HOP-STEP program, designed to boost provider confidence and ensure equitable care in pregnancy planning for lupus patients, is being tested against routine care practices to measure its effectiveness.See study design
What are the potential side effects?
Since this intervention focuses on education rather than medication or medical procedures, there are no direct side effects associated with it.

HOP-STEP sIRB Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

HOP-STEP sIRB Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intervention period, up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and intervention period, up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Contraception Documentation
Secondary outcome measures
Adoption: Providers that ever complete the HOP-STEP intervention
Degree of Adoption: Providers' completion of the HOP-STEP intervention
Effectiveness: ACR-aligned contraception
+9 more

HOP-STEP sIRB Trial Design

2Treatment groups
Experimental Treatment
Group I: Routine Care ProvidersExperimental Treatment1 Intervention
Care Providers in this arm will continue seeing patients as normal in clinic.
Group II: HOP-STEP (Healthy Outcomes in Pregnancy with SLE Through Education of Providers) ProvidersExperimental Treatment1 Intervention
HOP-STEP providers will inquire and document their patients about contraceptive usage and pregnancy interest, then provide personalized guidance on family planning.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Routine Care
2008
Completed Phase 4
~2150

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,351 Previous Clinical Trials
3,409,526 Total Patients Enrolled
University of ChicagoOTHER
995 Previous Clinical Trials
816,648 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,679 Previous Clinical Trials
6,910,662 Total Patients Enrolled

Media Library

HOP-STEP (Healthy Outcomes in Pregnancy with SLE Through Education of Providers) Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05818254 — N/A
Lupus Research Study Groups: HOP-STEP (Healthy Outcomes in Pregnancy with SLE Through Education of Providers) Providers, Routine Care Providers
Lupus Clinical Trial 2023: HOP-STEP (Healthy Outcomes in Pregnancy with SLE Through Education of Providers) Intervention Highlights & Side Effects. Trial Name: NCT05818254 — N/A
HOP-STEP (Healthy Outcomes in Pregnancy with SLE Through Education of Providers) Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05818254 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to enroll in this research endeavor?

"In accordance with the clinicaltrials.gov information, this medical experiment is not currently seeking patients. It was originally posted on May 1st 2023 and last updated April 17th 2023. While this trial isn't open to recruitment at present, there are still 190 other studies actively recruiting participants right now."

Answered by AI
~13 spots leftby Mar 2026